vs

Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Target Hospitality Corp. (TH). Click either name above to swap in a different company.

Target Hospitality Corp. is the larger business by last-quarter revenue ($73.5M vs $38.3M, roughly 1.9× ImmunityBio, Inc.). Target Hospitality Corp. runs the higher net margin — -20.3% vs -161.8%, a 141.5% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 22.0%).

ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.

Target Hospitality is a company that provides workforce lodging and other temporary, modular housing used for oil, gas and mining operations; large-scale events; and disaster relief. Target Hospitality is based in The Woodlands, Texas, and also has offices in Williston, North Dakota; Denver, Colorado; Calgary, Alberta.

IBRX vs TH — Head-to-Head

Bigger by revenue
TH
TH
1.9× larger
TH
$73.5M
$38.3M
IBRX
Growing faster (revenue YoY)
IBRX
IBRX
+385.0% gap
IBRX
407.0%
22.0%
TH
Higher net margin
TH
TH
141.5% more per $
TH
-20.3%
-161.8%
IBRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IBRX
IBRX
TH
TH
Revenue
$38.3M
$73.5M
Net Profit
$-61.9M
$-14.9M
Gross Margin
99.0%
9.6%
Operating Margin
-169.0%
-22.9%
Net Margin
-161.8%
-20.3%
Revenue YoY
407.0%
22.0%
Net Profit YoY
-4.7%
-219.1%
EPS (diluted)
$-0.06
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBRX
IBRX
TH
TH
Q4 25
$38.3M
$73.5M
Q3 25
$32.1M
$91.6M
Q2 25
$26.4M
$54.9M
Q1 25
$16.5M
$54.9M
Q4 24
$7.6M
$60.2M
Q3 24
$6.1M
$65.8M
Q2 24
$67.5M
Q1 24
$72.4M
Net Profit
IBRX
IBRX
TH
TH
Q4 25
$-61.9M
$-14.9M
Q3 25
$-67.3M
$-795.0K
Q2 25
$-92.6M
$-14.9M
Q1 25
$-129.6M
$-6.5M
Q4 24
$-59.2M
$12.5M
Q3 24
$-85.7M
$20.0M
Q2 24
$18.4M
Q1 24
$20.4M
Gross Margin
IBRX
IBRX
TH
TH
Q4 25
99.0%
9.6%
Q3 25
99.4%
19.6%
Q2 25
99.5%
-0.6%
Q1 25
99.6%
32.7%
Q4 24
61.5%
Q3 24
68.7%
Q2 24
69.4%
Q1 24
67.8%
Operating Margin
IBRX
IBRX
TH
TH
Q4 25
-169.0%
-22.9%
Q3 25
-173.5%
0.1%
Q2 25
-269.8%
-30.8%
Q1 25
-390.1%
-2.0%
Q4 24
-919.0%
34.5%
Q3 24
-1314.3%
42.5%
Q2 24
43.8%
Q1 24
42.0%
Net Margin
IBRX
IBRX
TH
TH
Q4 25
-161.8%
-20.3%
Q3 25
-209.8%
-0.9%
Q2 25
-350.3%
-27.2%
Q1 25
-784.9%
-11.8%
Q4 24
-783.4%
20.8%
Q3 24
-1404.0%
30.4%
Q2 24
27.2%
Q1 24
28.2%
EPS (diluted)
IBRX
IBRX
TH
TH
Q4 25
$-0.06
$-0.14
Q3 25
$-0.07
$-0.01
Q2 25
$-0.10
$-0.15
Q1 25
$-0.15
$-0.07
Q4 24
$-0.08
$0.12
Q3 24
$-0.14
$0.20
Q2 24
$0.18
Q1 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBRX
IBRX
TH
TH
Cash + ST InvestmentsLiquidity on hand
$242.8M
$8.3M
Total DebtLower is stronger
$1.7M
Stockholders' EquityBook value
$-500.5M
$389.3M
Total Assets
$501.9M
$530.2M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBRX
IBRX
TH
TH
Q4 25
$242.8M
$8.3M
Q3 25
$257.8M
$30.4M
Q2 25
$153.7M
$19.2M
Q1 25
$61.6M
$34.5M
Q4 24
$149.8M
$190.7M
Q3 24
$130.4M
$177.7M
Q2 24
$154.3M
Q1 24
$124.3M
Total Debt
IBRX
IBRX
TH
TH
Q4 25
$1.7M
Q3 25
$2.0M
Q2 25
$26.3M
Q1 25
$42.9M
Q4 24
$1.5M
Q3 24
$994.0K
Q2 24
$1.1M
Q1 24
$179.9M
Stockholders' Equity
IBRX
IBRX
TH
TH
Q4 25
$-500.5M
$389.3M
Q3 25
$-524.3M
$402.4M
Q2 25
$-570.7M
$401.3M
Q1 25
$-591.4M
$415.3M
Q4 24
$-489.1M
$421.1M
Q3 24
$-745.1M
$417.6M
Q2 24
$397.2M
Q1 24
$375.5M
Total Assets
IBRX
IBRX
TH
TH
Q4 25
$501.9M
$530.2M
Q3 25
$519.0M
$541.2M
Q2 25
$402.1M
$533.7M
Q1 25
$303.8M
$562.5M
Q4 24
$382.9M
$725.8M
Q3 24
$364.6M
$709.8M
Q2 24
$697.0M
Q1 24
$687.2M
Debt / Equity
IBRX
IBRX
TH
TH
Q4 25
0.00×
Q3 25
0.01×
Q2 25
0.07×
Q1 25
0.10×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBRX
IBRX
TH
TH
Operating Cash FlowLast quarter
$-70.4M
$5.7M
Free Cash FlowOCF − Capex
$-71.3M
FCF MarginFCF / Revenue
-186.2%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-308.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBRX
IBRX
TH
TH
Q4 25
$-70.4M
$5.7M
Q3 25
$-68.9M
$53.4M
Q2 25
$-79.7M
$11.1M
Q1 25
$-85.9M
$3.9M
Q4 24
$-85.1M
$30.6M
Q3 24
$-98.8M
$31.4M
Q2 24
$39.1M
Q1 24
$50.6M
Free Cash Flow
IBRX
IBRX
TH
TH
Q4 25
$-71.3M
Q3 25
$-69.6M
Q2 25
$-80.8M
Q1 25
$-87.0M
$-11.6M
Q4 24
$-87.3M
Q3 24
$-101.6M
Q2 24
Q1 24
FCF Margin
IBRX
IBRX
TH
TH
Q4 25
-186.2%
Q3 25
-217.2%
Q2 25
-305.9%
Q1 25
-526.9%
-21.1%
Q4 24
-1155.4%
Q3 24
-1663.2%
Q2 24
Q1 24
Capex Intensity
IBRX
IBRX
TH
TH
Q4 25
2.4%
Q3 25
2.3%
Q2 25
4.1%
Q1 25
6.8%
28.2%
Q4 24
28.0%
Q3 24
45.7%
Q2 24
Q1 24
Cash Conversion
IBRX
IBRX
TH
TH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
2.44×
Q3 24
1.57×
Q2 24
2.13×
Q1 24
2.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBRX
IBRX

Segment breakdown not available.

TH
TH

Services$40.9M56%
Hospitality And Facilities Services South$32.6M44%

Related Comparisons